Sexual Function: Quality of Life Issues in Patients with Locally Advanced Non-Metastatic Prostate Cancer

2002 ◽  
Vol 1 (7) ◽  
pp. 26-32 ◽  
Author(s):  
Peter Iversen ◽  
Don Newling ◽  
Roger Kirby ◽  
Ian Eardley
2017 ◽  
Vol 41 (6) ◽  
pp. 368-375
Author(s):  
I. López-Calderero ◽  
L. López-Fando ◽  
E. Ríos-González ◽  
P. Maisonobe ◽  
E. Hernández-Yuste ◽  
...  

2018 ◽  
Vol 15 (7) ◽  
pp. S285-S286
Author(s):  
K. Chaker ◽  
A. Sellami ◽  
Y. Ouanes ◽  
M.A. Essid ◽  
K. Mrad Dali ◽  
...  

2018 ◽  
Author(s):  
Kays Chaker ◽  
Ahmed Sellami ◽  
Yassine Ouanes ◽  
Mohamed Ali Essid ◽  
Karem Abid ◽  
...  

2020 ◽  
Vol 26 (8) ◽  
pp. 1997-2010
Author(s):  
Sharon Odeo ◽  
Amsalu Degu

Introduction Prostate cancer is recognized as the leading cause of malignancy-related incidence and mortality in the male population. The treatment regimens have long-term effects detrimental to the patient's quality of life. Hence, this review was aimed to determine the overall HRQOL and its associated among prostate cancer patients. Methods The review was performed according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. The databases searched were PubMed, Embase, Google Scholar and Cumulative Index to the Nursing and Allied Literature (CINAHL), which provided articles that were critically examined, yielding 52 studies that met the inclusion criteria for the systematic review. Results Out of 52 studies, 30 studies reported poor overall HRQOL in various domains after prostate cancer treatment. Contrastingly, 15 studies reported good overall quality of life after treatment. Among the various domains, sexual function was the most grossly affected functional score by the treatment modalities of prostate cancer. Nonetheless, seven studies showed that the absence of a significant change in the overall quality of life after treatment. According to the studies, older age, comorbidities, higher clinical stage, higher Gleason score, greater cancer severity, African American race, impaired mental health, neoadjuvant hormonal therapy and lower level of education were the major poor predictors of HRQOL among prostate cancer patients. Conclusion The overall HRQOL in prostate cancer patients was generally poor in various functional domains after treatment. Among the various domains, sexual function was the most grossly affected functional score by the treatment modalities of prostate cancer.


Sign in / Sign up

Export Citation Format

Share Document